Scott Polar Research InstituteSPRI library catalogue
Search the catalogue
Browse recordsView a record
Please note: You are viewing the legacy database of the Scott Polar Research Institute Library catalogue. It is no longer being updated, so does not reliably reflect our current library holdings.
Please search for material in iDiscover for up-to-date information about the library collection.
Record #187247:
- #187247
Main publication details
MARC recordVaccination policy and programs in the circumpolar world / P. Orr.
| Title: | Vaccination policy and programs in the circumpolar world / P. Orr. |
| Author(s): | Orr, P. |
| Date: | 2007. |
| In: | International Journal of Circumpolar Health. (2007.), Vol. 66(5) (2007) |
| Abstract: | Considers new vaccines against Pneumococcus, Meningococcus, Human Papilloma Virus (HPV) and Rotavirus currently being evaluated in circumpolar world. Argues that evaluation process should ensure that vaccine components and immunogenicity are suited to targeted Arctic population. Notes that, in Canada, licensed seven-valent pneumococcal conjugate vaccine does not include Serotype 1 which is significant cause of morbidity and mortality among Canadian aboriginal children. |
| Notes: | International Journal of Circumpolar Health. Vol. 66(5) :380-381 (2007). |
| Keywords: | 32 -- Politics. 612.017 -- Immunity. 614 -- Public health and safety. 616-036 -- Epidemiology. I -- Medicine and health. (*3) -- Arctic regions. |
| SPRI record no.: | 187247 |
LDR 01308naa#a2200000#a#4500 001 SPRI-187247 005 20230607165317.0 007 ta 008 230607s2007####xx####|##|###|0||#0|eng#d 035 ## ‡aSPRI-187247 040 ## ‡aUkCU-P‡beng‡eaacr 100 1# ‡aOrr, P. 245 10 ‡aVaccination policy and programs in the circumpolar world /‡cP. Orr. 260 ## ‡a[S.l.] :‡b[s.n.],‡c2007. 300 ## ‡ap. 380-381. 500 ## ‡aInternational Journal of Circumpolar Health. Vol. 66(5) :380-381 (2007). 520 3# ‡aConsiders new vaccines against Pneumococcus, Meningococcus, Human Papilloma Virus (HPV) and Rotavirus currently being evaluated in circumpolar world. Argues that evaluation process should ensure that vaccine components and immunogenicity are suited to targeted Arctic population. Notes that, in Canada, licensed seven-valent pneumococcal conjugate vaccine does not include Serotype 1 which is significant cause of morbidity and mortality among Canadian aboriginal children. 650 07 ‡a32 -- Politics.‡2udc 650 07 ‡a612.017 -- Immunity.‡2udc 650 07 ‡a614 -- Public health and safety.‡2udc 650 07 ‡a616-036 -- Epidemiology.‡2udc 650 07 ‡aI -- Medicine and health.‡2local 651 #7 ‡a(*3) -- Arctic regions.‡2udc 773 0# ‡7nnas ‡tInternational Journal of Circumpolar Health. ‡gVol. 66(5) (2007) ‡wSPRI-142401 916 ## ‡a2009/08/11 -- JW 917 ## ‡aUnenhanced record from Muscat, imported 2019 948 3# ‡a20230607 ‡bJW